C M Bidwell & Associates LTD Novartis Ag Transaction History

C M Bidwell & Associates LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$80.93 - $91.1 $117,348 - $132,095	-1,450 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$70.67 - $99.01 $20,140 - $28,217	-285 Reduced 16.43%	1,450 $120,000
Q4 2019 Feb 12, 2020	SELL	$84.35 - $95.37 $36,692 - $41,485	-435 Reduced 20.05%	1,735 $164,000
Q3 2019 Nov 13, 2019	BUY	$85.54 - $94.26 $185,621 - $204,544	2,170 New	2,170 $189,000
Q1 2018 May 11, 2018	SELL	$70.39 - $84.15 $173,511 - $207,429	-2,465 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$74.14 - $77.27 $182,755 - $190,470	2,465	2,465 $212,000

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of C M Bidwell & Associates LTD, based on Form 13F filings with the SEC.

Stay updated on C M Bidwell & Associates LTD with notifications on news.